Global Organoid Biobank Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Organoid Biobank Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Organoids refer to three-dimensional tissue structures constructed in vitro through cell engineering, tissue engineering or stem cell technology based on internal organs.
Organoid Biobank report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Organoid Biobank market is projected to reach US$ 390.4 million in 2033, increasing from US$ 121 million in 2022, with the CAGR of 18.5% during the period of 2023 to 2033. Demand from Biopharmaceutical Companies and Contract Research Organizations are the major drivers for the industry.
The organoid biobank market is a growing field that encompasses the collection, storage, and distribution of human organoid models and biological samples required for a variety of medical and biological research. Key drivers of this market include increased demand for medical research, advances in organ transplantation and drug testing, developments in biotechnology, and the rise of personalized medicine. These biobanks provide researchers and pharmaceutical companies with important resources for disease research, drug screening, and personalized medicine, and therefore have huge potential and market opportunities in the fields of medicine and life sciences.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Organoid Biobank market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
FRANKFURT CANCER INSTITUTE
Merck
Crown Bioscience
HUB Organoids
Cancer Research UK Convergence Science Centre
Thermo Fisher Scientific
Corning
STEMCELL Technologies
Lonza
Prellis Biologics
Amsbio
Cellesce
DefiniGEN
3Dnamics Inc.
Organoid Therapeutics
InSphero
AIVITA Biomedical
JangoBio
Segment by Type
Tissue Derived Organoids
Pluripotent Stem Cell-derived Organoids
Biopharmaceutical Companies
Contract Research Organizations
Academics and Research Institutes
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Organoid Biobank market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Organoid Biobank introduction, etc. Organoid Biobank Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Organoid Biobank market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
Organoid Biobank report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Organoid Biobank market is projected to reach US$ 390.4 million in 2033, increasing from US$ 121 million in 2022, with the CAGR of 18.5% during the period of 2023 to 2033. Demand from Biopharmaceutical Companies and Contract Research Organizations are the major drivers for the industry.
The organoid biobank market is a growing field that encompasses the collection, storage, and distribution of human organoid models and biological samples required for a variety of medical and biological research. Key drivers of this market include increased demand for medical research, advances in organ transplantation and drug testing, developments in biotechnology, and the rise of personalized medicine. These biobanks provide researchers and pharmaceutical companies with important resources for disease research, drug screening, and personalized medicine, and therefore have huge potential and market opportunities in the fields of medicine and life sciences.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Organoid Biobank market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
FRANKFURT CANCER INSTITUTE
Merck
Crown Bioscience
HUB Organoids
Cancer Research UK Convergence Science Centre
Thermo Fisher Scientific
Corning
STEMCELL Technologies
Lonza
Prellis Biologics
Amsbio
Cellesce
DefiniGEN
3Dnamics Inc.
Organoid Therapeutics
InSphero
AIVITA Biomedical
JangoBio
Segment by Type
Tissue Derived Organoids
Pluripotent Stem Cell-derived Organoids
Segment by Application
Biopharmaceutical Companies
Contract Research Organizations
Academics and Research Institutes
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Organoid Biobank market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Organoid Biobank introduction, etc. Organoid Biobank Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Organoid Biobank market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.